HemOnc.org - A Free Hematology/Oncology Reference

Regimens: 4,428		Regimen variants: 6,546
Solid Tumors	Malignant Hematology	Transplant	Classical Hematology
Mobile Version	Editorial Board		Desktop Version
Disease index	Drug index	Regimen index	General reference

If this is your first time visiting, please go to the tutorial page or just start exploring!

Links to all main disease pages

Solid Tumors
Breast Oncology
Breast cancer	Breast cancer, HER2-positive	Breast cancer, triple negative (TNBC)
Dermatologic Oncology
Melanoma	Melanoma, BRAF-mutated	Skin, basal & squamous cancer	Merkel cell carcinoma
Endocrine Oncology
Adrenocortical carcinoma	Neuroendocrine tumors	Pancreatic NET	Pheochromocytoma
Thyroid cancer
Gastrointestinal Oncology
Anal cancer	Cholangiocarcinoma	Colon cancer	Esophageal cancer
Gastric cancer	Gastrointestinal stromal tumor (GIST)	Hepatocellular carcinoma	Periampullary adenocarcinoma
Pancreatic cancer	Pancreatic NET	Rectal cancer
Genitourinary Oncology
Bladder cancer	Penile cancer	Prostate cancer	Renal cancer (RCC)
Testicular cancer
Gynecologic Oncology
Cervical cancer	Ovarian cancer	Uterine cancer
Head & Neck Oncology
Head and neck cancer	Nasopharyngeal carcinoma	Thyroid cancer
Neuro-Oncology
Anaplastic glioma	Glioblastoma	Low-grade glioma	Meningioma
Pediatric Oncology
Neuroblastoma
Sarcoma
Bone sarcoma	Ewing's sarcoma	Gastrointestinal stromal tumor (GIST)	Osteosarcoma
Soft tissue sarcoma (STS)	Vascular sarcoma
Thoracic Oncology
Esophageal cancer	Lung cancer, non-small cell (NSCLC)	NSCLC, ALK-positive	NSCLC, BRAF-mutated
NSCLC, EGFR-mutated	Lung cancer, small cell (SCLC)	Mesothelioma	Thymoma
Site-agnostic
MSI-H or dMMR	Adenocarcinoma of unknown primary	NET of unknown primary	SCC of unknown primary

back to top

Malignant Hematology
Acute leukemias
Acute myeloid leukemia (AML)	AML, FLT3-positive	AML, IDH-mutated	Acute promyelocytic leukemia (APL)
B-cell acute lymphoblastic leukemia (B-ALL)	B-ALL, Ph+	T-cell acute lymphoblastic leukemia (T-ALL)	CNS leukemia
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML)	Chronic myelomonocytic leukemia (CMML)	Essential thrombocythemia (ET)	Hypereosinophilic syndrome (HES)
Myelodysplastic syndrome	Primary & secondary myelofibrosis	Polycythemia vera (PV)	Systemic mastocytosis
Aggressive lymphomas
Burkitt lymphoma (BL) or Burkitt-like lymphoma	CNS lymphoma	Diffuse large B-cell lymphoma (DLBCL)	HIV-associated lymphoma
Hodgkin lymphoma (HL)	Mantle cell lymphoma (MCL)	Mediastinal gray-zone lymphoma (MGZL)	Primary mediastinal B-cell lymphoma (PMBL)
Transformed lymphoma (TL)
Indolent lymphomas
Chronic lymphocytic leukemia (CLL/SLL)	Follicular lymphoma (FL)	Hairy cell leukemia (HCL)	Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)
Marginal zone lymphoma (MZL)	Waldenström macroglobulinemia (WM/LPL)
Plasma cell dyscrasias
Light-chain (AL) amyloidosis	Multiple myeloma (MM)	Plasma cell leukemia	POEMS
T-cell and NK-cell neoplasms
Adult T-cell leukemia-lymphoma (ATLL)	Anaplastic large cell lymphoma (ALCL)	Cutaneous T-cell lymphoma (CTCL)	Extranodal NK/T-cell lymphoma, nasal type
Large granular lymphocytic (LGL) leukemia	NK/T-cell lymphoma	Peripheral T-cell Lymphoma (PTCL)	T-cell acute lymphoblastic lymphoma (T-LBL)
Lymphoproliferative disorders
Castleman disease		Post-transplant lymphoproliferative disorder (PTLD)
Histiocyte disorders
Erdheim-Chester disease	Hemophagocytic lymphohistiocytosis (HLH)	Langerhans cell histiocytosis

back to top

Transplant
Stem cell mobilization	Allogeneic HSCT	Autologous HSCT	Graft versus host disease (GVHD)

back to top

Classical Hematology
Hemostasis and thrombosis
Acquired coagulopathy	Inherited coagulopathy	Inherited thrombophilia	Venous thromboembolism (VTE)
Cytopenias
Aplastic anemia	Autoimmune cytopenias	Autoimmune thrombocytopenic purpura (ITP)	Heparin-induced thrombocytopenia (HIT)
Hemolytic disorders
Atypical hemolytic-uremic syndrome (aHUS)	Autoimmune hemolytic anemia (AIHA)	Cold agglutinin disease	Paroxysmal nocturnal hemoglobinuria (PNH)
Sickle cell anemia	Thrombotic thrombocytopenic purpura (TTP)

Browse our complete index of pages

Additional Information

Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes continuous peer review.

Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

1. Creating a database of chemotherapy agents and other medications.
2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
3. Sample order sets and examples of supportive medications used with treatment regimens
4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

1. Creating summaries of pivotal clinical trials
2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
3. Checklists for common clinical scenarios/diseases
4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.